Yahoo
NasdaqCM - Delayed Quote USD

Rockwell Medical, Inc. (RMTI)

7.73 +0.13 (+1.71%)
At close: November 6 at 4:00:00 PM EST
Chart Range Bar
Loading chart for RMTI
  • Previous Close 7.60
  • Open 7.52
  • Bid 7.62 x 100
  • Ask 7.73 x 100
  • Day's Range 7.22 - 7.99
  • 52 Week Range 4.89 - 12.90
  • Volume 16,146
  • Avg. Volume 26,896
  • Market Cap (intraday) 31.155M
  • Beta (5Y Monthly) 1.73
  • PE Ratio (TTM) --
  • EPS (TTM) -1.34
  • Earnings Date Nov 12, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 20.00
  • Moby Rating Neutral

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

www.rockwellmed.com

157

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

RMTI
6.87%
S&P 500 (^GSPC)
7.76%

1-Year Return

RMTI
23.47%
S&P 500 (^GSPC)
9.77%

3-Year Return

RMTI
59.95%
S&P 500 (^GSPC)
68.96%

5-Year Return

RMTI
86.74%
S&P 500 (^GSPC)
57.04%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 17.34M
Earnings -1.6M
Profit Margin -9.26%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
5M
10M
15M
-10.0%
-8.0%
-6.0%
-4.0%

Analyst Insights

View More

Analyst Price Targets

20.00
20.00 Average
7.73 Current
20.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/11/2026
Analyst HC Wainwright & Co.
Rating Action Reiterates
Rating Buy
Price Action Maintains
Price Target 20 -> 20

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -7.33%

  • Return on Assets (ttm)

    -5.18%

  • Return on Equity (ttm)

    -15.52%

  • Revenue (ttm)

    69.39M

  • Net Income Avi to Common (ttm)

    -5.24M

  • Diluted EPS (ttm)

    -1.34

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    24.8M

  • Total Debt/Equity (mrq)

    39.71%

  • Levered Free Cash Flow (ttm)

    350.38k

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: